MGMT and glioblastoma: In addition, even though TMZ had an anti-GBM effect (Hegi et al., 2019), the MOS of patients with MGMT promoter hypermethylated was only 18.4 months, compared to 6.7 months for those patients without MGMT promoter methylation (Wick et al., 2020).